Pfizer, on Monday, said it has registered a net profit of Rs.48.10 crore in the fourth quarter ended March 31, 2012, against Rs.63.14 crore in the year-ago period.
Sales stood at Rs.251.73 crore against Rs.293.17 crore, Pfizer said in its communication to the BSE.
For the year ended March 31, 2012, it posted a net profit of Rs.184.61 crore against Rs.226.34 crore during the 16-months ended March 31, 2011. Sales stood at Rs.1,017.30 crore against Rs.1,169.56 crore. The board has recommended a dividend of Rs.12.5 per share for the year ended March 31, 2012.
The company said that its pharmaceutical division reported revenue of Rs.216.34 crore in the quarter under review against Rs.251.17 crore.
Slump sale
The company said it has changed its accounting year from December-November to April-March with effect from December 2009.
The business operation of animal health division was transferred to the wholly-owned subsidiary on April 2, 2012, by way of slump sale for a consideration of Rs.440 crore, subject to adjustment for working capital, the company said.
Meanwhile, the company said that Bomi M. Gagrat, non-Executive Director of the company, had resigned from the board on Monday. It has appointed Uday Khanna, Sunil Madhok and Vivek Dhariwal as additional directors, it said.
